Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX0BQC
|
||||
| Drug Name |
N-((S)-4-cyclohexyl-1-((S)-1-(5-fluoroindolin-1-yl)-4-morpholinobutan-2-ylamino)-1-oxobutan-2-yl)-3-methoxybenzamide
|
||||
| Synonyms |
CHEMBL203052
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C34H47FN4O4
|
||||
| Canonical SMILES |
COc1cccc(c1)C(=O)N[C@@H](CCC2CCCCC2)C(=O)N[C@@H](CCN3CCOCC3)CN4CCc5cc(F)ccc45
|
||||
| InChI |
InChI=1S/C34H47FN4O4/c1-42-30-9-5-8-27(23-30)33(40)37-31(12-10-25-6-3-2-4-7-25)34(41)36-29(15-16-38-18-20-43-21-19-38)24-39-17-14-26-22-28(35)11-13-32(26)39/h5,8-9,11,13,22-23,25,29,31H,2-4,6-7,10,12,14-21,24H2,1H3,(H,36,41)(H,37,40)/t29-,31-/m0/s1
|
||||
| InChIKey |
BFHDYXSSAAUGPU-SMCANUKXSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.